|Bid||14.94 x 3000|
|Ask||15.90 x 3200|
|Day's Range||15.21 - 15.57|
|52 Week Range||13.10 - 23.25|
|Beta (5Y Monthly)||1.03|
|PE Ratio (TTM)||3.21|
|Earnings Date||Nov 02, 2022 - Nov 07, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Oct 07, 2008|
|1y Target Est||22.00|
CHICAGO, September 19, 2022--Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) will host a virtual Investor Day on Wednesday, September 28, 2022 at 12:00 p.m. (Eastern). The event will include presentations made by members of the executive management team followed by a question-and-answer session. Participants may access the virtual conference by registering with our webcast registration or dial-in registration (for Q&A) links. Presentation slides will be posted on the day of the event, at ap
CHICAGO, September 14, 2022--Veradigm®, a leading provider of healthcare data and technology solutions and a business unit of Allscripts Healthcare Solutions (NASDAQ: MDRX), and Vytalize Health, a new kind of Medicare ACO focused on helping primary care doctors manage their Medicare patients, announced today a new agreement for Vytalize Health to integrate its solutions and services directly into the Practice Fusion EHR, a Veradigm Network solution.
Investors continue to be optimistic about Allscripts (MDRX) owing to its strategic alliances.